 | Up a level |
Martinho-Grueber, Maude; Kapoglou, Ioannis; Bravo, Francisco; Sarraj, Riad; Benz, Eileen; Restellini, Sophie; Biedermann, Luc; Rogler, Gerhard; Vavricka, Stephan R; Schoepfer, Alain; Maillard, Michel H; Michetti, Pierre; Brunner, Felix; Clair, Carole; Pathe Barry, Mamadou; Pittet, Valérie; von Känel, Roland; Juillerat, Pascal (2023). Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease. European journal of gastroenterology & hepatology, 35(1), pp. 21-30. Wolters Kluwer 10.1097/MEG.0000000000002453
Bravo, Francisco; Lenglinger, Johannes; Borbély, Yves; Wiest, Reiner (2023). Wenn der Magen „nicht mehr richtig schafft“. Schweizer Gastroenterologie, 4(2), pp. 64-77. Springer 10.1007/s43472-023-00100-x
Bravo, Francisco; Kapoglou, Ioannis; Bionda, Marion; Macpherson, Andrew J; Krupka, Niklas (2021). Progressive malnutrition despite percutaneous endoscopic gastrostomy. Frontline gastroenterology, 12(6), pp. 535-536. BMJ Publishing Group 10.1136/flgastro-2020-101413
Bravo, Francisco; Macpherson, Jamie A; Slack, Emma; Patuto, Nicola; Cahenzli, Julia; McCoy, Kathy D.; Macpherson, Andrew J.; Juillerat, Pascal (2021). Prospective Validation of CD-62L (L-Selectin) as Marker of Durable Response to Infliximab Treatment in Patients With Inflammatory Bowel Disease: A 5-Year Clinical Follow-up. Clinical and translational gastroenterology, 12(2), e00298. Wolters Kluwer Health 10.14309/ctg.0000000000000298
